Plasma levels of tumor necrosis factor-alpha in patients with panic disorder: effect of alprazolam therapy (Q60441445)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10643874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Plasma levels of tumor necrosis factor-alpha in patients with panic disorder: effect of alprazolam therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10643874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10643874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

F Brambilla

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10643874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

L Bellodi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10643874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10643874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10643874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10643874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10643874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

21-27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10643874%20AND%20SRC:MED&resulttype=core&format=json

Immunity, major depression, and panic disorder comorbidity

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Immunoregulation mediated by the sympathetic nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Psychoimmunoendocrine aspects of panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Plasma interleukin-1 beta concentrations in panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Neuroendocrine regulation of in vivo cytokine production and effects: I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Interleukin-1 affects the behavioral despair response in rats by an indirect mechanism which requires endogenous CRF.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Diurnal and acute stress-induced changes in distribution of peripheral blood leukocyte subpopulations.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Reduction of exploratory behavior by intraperitoneal injection of interleukin-1 involves brain corticotropin-releasing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Continuous in vivo treatment with catecholamines suppresses in vitro reactivity of rat peripheral blood T-lymphocytes via alpha-mediated mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

A neuroanatomical hypothesis for panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Circadian variations in antigen-specific proliferation of human T lymphocytes and correlation to cortisol production

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Implications of altered limbic-hypothalamic-pituitary-adrenocortical (LHPA)-function for neurobiology of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Impaired lymphocyte stimulation by mitogens in severely depressed patients. A complex interface with HPA-axis hyperfunction, noradrenergic activity and the ageing process

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Immune Cell Imbalance in Major Depressive and Panic Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Natural killer cell activity in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Tumour necrosis factor-alpha and interleukin-2 differentially affect hippocampal serotonergic neurotransmission, behavioural activity, body temperature and hypothalamic-pituitary-adrenocortical axis activity in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Abnormal diurnal variation of B lymphocyte circulation patterns in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

A comparative study of immune status in panic disorder patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Serum interleukin-2 and soluble interleukin-2 receptor levels in generalized social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Immunological response to stress in agoraphobia and panic attacks.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Norepinephrine inhibits human natural killer cell activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

Circadian rhythmometry of serum interleukin-2, interleukin-10, tumor necrosis factor-alpha, and granulocyte-macrophage colony-stimulating factor in men

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900091-8

7 January 2021

10.1016/S0165-1781(99)00091-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10643874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference